Publication & Citation Trends
Publications
0 total
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Cited by 195
Semantic Scholar
OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN
Cited by 0
Semantic Scholar
175POHERA: A real world study of cardiac events in > 3700 patients with her2-positive early breast cancer treated with trastuzumab: Final analysis OA
Cited by 2
Semantic Scholar
Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study OA
Cited by 0
Semantic Scholar
1348P Overall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: results from two phase II studies.
Cited by 4
Semantic Scholar
BERIL-1: A phase II, placebo-controlled study of buparlisib (BKM120) plus paclitaxel in patients with platinum-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).
Cited by 12
Semantic Scholar
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part) OA
Cited by 68
Semantic Scholar
Research Topics
Head and Neck Cancer Studies
(7)
Lung Cancer Treatments and Mutations
(7)
Cancer Immunotherapy and Biomarkers
(3)
Colorectal Cancer Treatments and Studies
(3)
Cancer Treatment and Pharmacology
(3)
Affiliations
National Institute of Oncology
Jósa András Múzeum
Szent Imre Egyetemi Oktatókórház